Julie Yoakum
Known title: See RemarksCIK: 0001552535
Associated companies
Transaction History
| SIG | ▼ Sell | Tax Withholding | 2,646 | $218K | 8/31/2026 | View on chart |
| SIG | ▲ Buy | Grant | 52 | $0 | 8/21/2026 | View on chart |
| SIG | ▲ Buy | Grant | 53 | $0 | 5/22/2026 | View on chart |
| SIG | ▲ Buy | Grant | 4,013 | $0 | 3/24/2026 | View on chart |
| SIG | ▲ Buy | Grant | 27 | $0 | 2/20/2026 | View on chart |
| SIG | ▲ Buy | Grant | 28 | $0 | 11/21/2025 | View on chart |
| SIG | ▲ Buy | Grant | 8,073 | $0 | 8/31/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher
Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher. Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.